The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn’s Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, later randomized controlled trials yielded mixed results, with some failing to demonstrate clear clinical benefit over placebo, possibly due to high placebo response rates or insufficient treatment duration”
From Parasites and allergies: a complex bidirectional relationship from evolutionary origins to modern therapeutics (2026) · cites this paper as Jaeger et al. 2018
In the citing paper
“Across multiple studies, helminth therapy with T. suis and N. americanus was generally found to be safe and well-tolerated, though efficacy results were inconsistent and often limited by study design or high placebo effects”
From Parasites and allergies: a complex bidirectional relationship from evolutionary origins to modern therapeutics (2026) · cites this paper as Jaeger et al. 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Institute of Diabetes and Digestive Kidney Diseases Inflammatory Bowel Disease Genetics Consortium (NIDDK IBDGC), Rivas, M. A., United Kingdom Inflammatory Bowel Disease Genetics Consortium, International Inflammatory Bowel Disease Genetics Consortium, Beaudoin, M., Gardet, A., Stevens, C., Sharma, Y., Zhang, C. K., Boucher, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.952 · Cited by 771
Ramanan, D., Tang, M. S., Bowcutt, R., Loke, P., & Cadwell, K. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.015 · Cited by 269
Research works printed but not linked: 19
- Al Nabhani, 2016, Nod2 deficiency leads to a specific and transmissible mucosa-associated microbial dysbiosis which is independent of the mucosal barrier defect., J. Crohns Colitis, 10, 1428, 10.1093/ecco-jcc/jjw095 · DOI
- Bowcutt, 2014, A role for the pattern recognition receptor Nod2 in promoting recruitment of CD103 + + dendritic cells to the colon in response to Trichuris muris infection., Mucosal Immunol., 7, 1094, 10.1038/mi.2013.125 · DOI
- Carmody, 2015, Diet dominates host genotype in shaping the murine gut microbiota., Cell Host Microbe, 17, 72, 10.1016/j.chom.2014.11.010 · DOI · Paper page
- Cleynen, 2016, Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study., Lancet, 387, 156, 10.1016/S0140-6736(15)00465-1 · DOI
- González, 2007, SNPassoc: an R package to perform whole genome association studies., Bioinformatics, 23, 644, 10.1093/bioinformatics/btm025 · DOI
- Hiemstra, 2014, Excreted/secreted Trichuris suis products reduce barrier function and suppress inflammatory cytokine production of intestinal epithelial cells., Mol. Immunol., 60, 1, 10.1016/j.molimm.2014.03.003 · DOI
- Hugot, 2001, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease., Nature, 411, 599, 10.1038/35079107 · DOI · Paper page
- Kennedy, 2018, The impact of NOD2 variants on fecal microbiota in Crohn’s disease and controls without Gastrointestinal disease., Inflamm. Bowel Dis., 24, 583, 10.1093/ibd/izx061 · DOI
- Nelson, 2016, The genetics of drug efficacy: opportunities and challenges., Nat. Rev. Genet., 17, 197, 10.1038/nrg.2016.12 · DOI
- 2017, A Language and Environment for Statistical Computing.
- Ramanan, 2016, Helminth infection promotes colonization resistance via type 2 immunity., Science, 352, 608, 10.1126/science.aaf3229 · DOI
- Sandborn, 2013, Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn’s disease., Aliment. Pharmacol. Ther., 38, 255, 10.1111/apt.12366 · DOI
- Schölmerich, 2017, A randomised, double-blind, placebo-controlled trial of Trichuris suis ova in active Crohn’s disease., J. Crohns Colitis, 11, 390, 10.1093/ecco-jcc/jjw184 · DOI · Paper page
- Schwab, 2003, Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis., Gastroenterology, 124, 26, 10.1053/gast.2003.50010 · DOI
- Shanahan, 2014, Mouse Paneth cell antimicrobial function is independent of Nod2., Gut, 63, 903, 10.1136/gutjnl-2012-304190 · DOI
- Sinnwell, 2018, haplo.stats: Statistical Analysis of Haplotypes with Traits and Covariates when Linkage Phase is Ambiguous. R Package Version 1.7.7.
- Summers, Trichuris suis therapy in Crohn’s disease., Gut, 54, 87, 10.1136/gut.2004.041749 · DOI · Paper page
- Summers, Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial., Gastroenterology, 128, 825, 10.1053/j.gastro.2005.01.005 · DOI · Paper page
- Wehkamp, 2004, NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal alpha-defensin expression., Gut, 53, 1658, 10.1136/gut.2003.032805 · DOI
Cited by
Sorted by citations
Packi, K., Świerczewski, D., Klimczak, S., Ochab, D., Gałęziewska, J., Gromek, P., Kruczkowska, W., Płuciennik, E., Kałuzińska-Kołat, Ż., & Kołat, D. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02425-4
Metadata
- Authors
- Jaeger, S. U., Schaeffeler, E., Winter, S., Tremmel, R., Schölmerich, J., Malek, N., Stange, E. F., Schwab, M., & Wehkamp, J.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-07-16
- Volume
- 9
- ISSN
- 1663-9812
- PMC
- PMC6054957
- Cited by
- 3
- References
- 2
- Funders
- Deutsche Forschungsgemeinschaft (Heisenberg Programme)
- Robert Bosch Stiftung (Robert Bosch Stiftung is the founding body of Margarete Fischer-Bosch Institute of Pharmacology)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review